Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELTI study of ethanol lock therapy in TPN patients with suspected catheter-related bloodstream infection
NL-OMON23991Not yet recruiting
- Sponsor
- AMC Health
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in catheter-associated bloodstream infection (CRBSI) comparing Ethanol lock therapy with Placebo lock therapy (2 arms). Primary endpoints: Persistent bacteremia beyond 72 hours, Recurrence of bacteremia within 24 weeks and 2 more. Planned start Sep 2008; status: not yet recruiting.
02
Drugs
ethanol
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NL-OMON23991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23991.